Related Experiment Video
Updated: Apr 5, 2026

Olfactory Assays for Mouse Models of Neurodegenerative Disease
Published on: August 25, 2014
Distinguishing Alzheimer's disease and dementia with Lewy bodies using cognitive and olfactory measures
Holly James Westervelt1, Jared M Bruce2, Melanie A Faust3
1Department of Neurology, Vanderbilt University Medical Center.
Objective:
Given poor sensitivity of the diagnostic criteria in identifying dementia with Lewy bodies (DLB), the use of cognitive and olfactory measures to distinguish Alzheimer's disease (AD) from DLB was assessed.
Method:
Twenty-six patients with DLB and 60 patients with AD were administered several cognitive measures and the Brief Smell Identification Task (BSIT).
Result:
Patients with DLB performed significantly worse on the BSIT and visuoconstruction tasks than patients with AD, but significantly better on delayed recall of a word list. Sensitivity and specificity of these measures in identifying DLB are presented for each of these tasks alone and in combination. The best balance of sensitivity and specificity was found with a combination of the Hopkins Verbal Learning Test and BSIT (81% sensitivity, 90% specificity).
Conclusions:
These data have practical implications by providing cut scores than can be used to emphasize either specificity or sensitivity in identifying patients with DLB.
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Olfaction
The olfactory receptors are embedded in the cilia of the...

